Biotech

All Articles

Lykos will certainly talk to FDA to reevaluate its selection adhering to denial of MDMA treatment for trauma

.Adhering to a poor presenting for Lykos Therapies' MDMA candidate for post-traumatic stress disorde...

AN 2 halves roll call, quits phase 3 test after records let down

.AN2 Therapies is actually re-thinking its own service in response to lackluster midphase informatio...

Merck pays out $700M for bispecific, spying autoimmune position and also possibility to test Amgen in cancer cells

.Merck &amp Co. is actually paying $700 thousand upfront to test Amgen in a blood cancer cells marke...

Gilead pays J&ampJ $320M to go out licensing package for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its own liver disease medicine seladelpar,...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks can easily find the business setting up camping tents at basecamp responsible for E...

Entero laying off personnel, vacating office and also stopping briefly R&ampD

.Bed mattress Liquidators has transformed Entero Therapies white as a slab. The financial institutio...

Exelixis goes down ADC after determining it's no match for Tivdak

.Exelixis is quiting on its own cells element (TF)- targeting antibody-drug conjugate after wrapping...

Relay loses interest in SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech unit bowed out an SHP2 inhibitor treaty, Relay Rehab has actual...

Stoke's Dravet syndrome med discharged of predisposed professional hold

.Stoke Therapeutics' Dravet syndrome medication has been actually freed from a partial hold, getting...

Fierce Biotech's Gabrielle Masson presents Intense 15 at NYSE

.Intense Biotech Associate Editor Gabrielle Masson provided the 2024 training class of Fierce 15 vic...